Incyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. 

CEO
William J. Meury
CEOWilliam J. Meury
Employees
2,844
Employees2,844
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
1991
Founded1991
Employees
2,844
Employees2,844

INCY Key Statistics

Market cap
19.52B
Market cap19.52B
Price-Earnings ratio
13.73
Price-Earnings ratio13.73
Dividend yield
Dividend yield
Average volume
1.30M
Average volume1.30M
High today
$97.94
High today$97.94
Low today
$95.15
Low today$95.15
Open price
$95.90
Open price$95.90
Volume
436.54K
Volume436.54K
52 Week high
$112.29
52 Week high$112.29
52 Week low
$63.51
52 Week low$63.51

Stock Snapshot

The current Incyte(INCY) stock price is $97.72, with a market capitalization of 19.52B. The stock trades at a price-to-earnings (P/E) ratio of 13.73.

On 2026-05-21, Incyte(INCY) stock traded between a low of $95.15 and a high of $97.94. Shares are currently priced at $97.72, which is +2.7% above the low and -0.2% below the high.

The Incyte(INCY)'s current trading volume is 436.54K, compared to an average daily volume of 1.3M.

During the past year, Incyte(INCY) stock moved between $63.51 at its lowest and $112.29 at its peak.

During the past year, Incyte(INCY) stock moved between $63.51 at its lowest and $112.29 at its peak.

INCY News

Investing.com 8h
Incyte stock price target maintained at $135 by H.C. Wainwright - Investing.com

...

Incyte stock price target maintained at $135 by H.C. Wainwright - Investing.com
TipRanks 1d
Incyte, Genesis Molecular AI announce expansion of collaboration

Incyte (INCY) and Genesis Molecular AI announced a significant expansion of their strategic collaboration building and deploying AI to accelerate the discovery...

Analyst ratings

53%

of 30 ratings
Buy
36.7%
Hold
53.3%
Sell
10%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.